Get the Stockscreener App
6.89
3.61%
0.24
After Hours:
6.89
Ardelyx Inc stock is traded at $6.89, with a volume of 3.18M.
It is up +3.61% in the last 24 hours and up +11.49% over the past month.
Ardelyx Inc is a biotechnology company focused on the discovery, development, and commercialization of innovative, first-in-class medicines that meet significant unmet medical needs. The company has a proprietary drug discovery and design platform. Its lead product candidate is tenapanor, which aims to reduce the absorption of dietary sodium and phosphorus for the treatment of kidney disease, irritable bowel syndrome with constipation, and hyperphosphatemia in patients with dialysis.
See More
Previous Close:
$6.65
Open:
$6.61
24h Volume:
3.18M
Relative Volume:
0.79
Market Cap:
$1.60B
Revenue:
$159.11M
Net Income/Loss:
$-65.81M
P/E Ratio:
-57.42
EPS:
-0.12
Net Cash Flow:
$-81.12M
1W Performance:
+16.39%
1M Performance:
+11.49%
6M Performance:
-5.62%
1Y Performance:
+68.87%
1-Day Range:
$6.61
$6.955
1-Week Range:
$5.72
$7.18
52-Week Range:
$3.16
$10.13
Ardelyx Inc Stock (ARDX) Company Profile
Name
Ardelyx Inc
Sector
Industry
Phone
510-745-7047
Address
34175 ARDENWOOD BLVD., FREMONT, CA
Ardelyx Inc Stock (ARDX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-02-24 | Downgrade | Piper Sandler | Overweight → Neutral |
| Apr-05-24 | Initiated | Leerink Partners | Outperform |
| Dec-18-23 | Initiated | Raymond James | Strong Buy |
| Sep-07-23 | Initiated | H.C. Wainwright | Buy |
| Aug-25-23 | Upgrade | Cantor Fitzgerald | Neutral → Overweight |
| Mar-03-23 | Upgrade | Wedbush | Neutral → Outperform |
| Nov-17-22 | Upgrade | Piper Sandler | Neutral → Overweight |
| May-06-22 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Dec-01-21 | Upgrade | Ladenburg Thalmann | Neutral → Buy |
| Oct-14-21 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
| Jul-21-21 | Downgrade | Jefferies | Buy → Hold |
| Jul-20-21 | Downgrade | Piper Sandler | Overweight → Neutral |
| Jul-20-21 | Downgrade | Wedbush | Outperform → Neutral |
| Mar-23-21 | Initiated | Wedbush | Outperform |
| Jan-06-21 | Initiated | Cantor Fitzgerald | Overweight |
| Oct-20-20 | Resumed | Citigroup | Buy |
| Feb-18-20 | Resumed | Jefferies | Buy |
| Feb-12-20 | Initiated | Citigroup | Buy |
| Feb-10-20 | Initiated | Cowen | Outperform |
| Apr-08-19 | Initiated | Piper Jaffray | Overweight |
| Aug-24-18 | Initiated | Jefferies | Buy |
| Mar-19-18 | Resumed | Leerink Partners | Outperform |
| Nov-29-17 | Reiterated | Citigroup | Buy |
| Nov-22-17 | Reiterated | Ladenburg Thalmann | Buy |
| Oct-17-17 | Resumed | Leerink Partners | Outperform |
| Mar-31-16 | Initiated | Ladenburg Thalmann | Buy |
| Mar-09-16 | Initiated | Cantor Fitzgerald | Buy |
| Mar-03-16 | Initiated | Citigroup | Buy |
View All
Ardelyx Inc Stock (ARDX) Latest News
Top investors say Ardelyx Inc (ARDX) ticks everything they need - SETE News
Shareholders of Ardelyx, Inc. Should Contact Levi & Korsinsky Before October 15, 2024 to Discuss Your Rights – ARDX - GlobeNewswire
Investors who Lost Money on Ardelyx, Inc. (ARDX) Should Contact Levi & Korsinsky About Pending Class ActionARDX - AccessWire
Institutional investors control 61% of Ardelyx, Inc. (NASDAQ:ARDX) and were rewarded last week after stock increased 12% - Simply Wall St
Faruqi & Faruqi Reminds Ardelyx Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 15, 2024ARDX - PR Newswire
Levi & Korsinsky Notifies Ardelyx, Inc. Investors of a Class Action Lawsuit and Upcoming DeadlineARDX - AccessWire
Ardelyx (NASDAQ:ARDX) Trading 6.3% Higher - MarketBeat
ROSEN, A LONGSTANDING LAW FIRM, Encourages Ardelyx, Inc. - GlobeNewswire
ROSEN, A LONGSTANDING LAW FIRM, Encourages Ardelyx, Inc. Investors to Secure Counsel Before - The Bakersfield Californian
ROSEN, A LONGSTANDING LAW FIRM, Encourages Ardelyx, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – ARDX - GlobeNewswire Inc.
Ardelyx, Inc. (NASDAQ:ARDX) Receives Consensus Recommendation of "Buy" from Analysts - MarketBeat
Michael Raab Sells 3,000 Shares of Ardelyx, Inc. (NASDAQ:ARDX) Stock - MarketBeat
Ardelyx CEO Michael Raab sells $18,210 in company stock - Investing.com India
Ardelyx CEO Michael Raab sells $18,210 in company stock By Investing.com - Investing.com Australia
Ardelyx CEO Michael Raab sells $18,210 in company stock - Investing.com
ARDX SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Ardelyx, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - AccessWire
Taking a look at what insiders are doing to gauge the Ardelyx Inc (ARDX)’s direction - Knox Daily
Ardelyx CEO Michael Raab sells $18,210 in company stock By Investing.com - Investing.com UK
Class Action Filed Against Ardelyx, Inc. (ARDX)October 15, 2024 Deadline to JoinContact Levi & Korsinsky - AccessWire
Ardelyx Inc [ARDX] stock Downgrade by Piper Sandler analyst, price target now $7 - The DBT News
Class Action Filed Against Ardelyx, Inc. (ARDX)October 15, 2024 Deadline to Join -– Contact Levi & Korsinsky - AccessWire
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Ardelyx - Stockhouse Publishing
Ardelyx, Inc. Sued for Securities Law ViolationsContact Levi & Korsinsky Before October 15, 2024 to Discuss Your RightsARDX - AccessWire
October 15, 2024 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against ARDX - PR Newswire
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Ardelyx - Marketscreener.com
Kirby McInerney LLP Announces the Filing of a Securities Class Action on Behalf of Nano Ardelyx, Inc. (ARDX) Investors - Business Wire
Shareholders that lost money on Ardelyx, Inc.(ARDX) should contact Levi & Korsinsky about pending Class ActionARDX - AccessWire
The growth track for Ardelyx Inc (ARDX) has changed recently - SETE News
Ardelyx Inc Inc. (ARDX) Price Performance: A Comparative Analysis with Competitors - The InvestChronicle
Investors in Ardelyx, Inc. Should Contact The Gross Law Firm Before October 15, 2024 to Discuss Your RightsARDX - Longview News-Journal
Commonwealth Equity Services LLC Sells 2,276 Shares of Ardelyx, Inc. (NASDAQ:ARDX) - Defense World
Bragar Eagel & Squire, P.C. Reminds Investors That Class - GlobeNewswire
2024-09-25 | Ardelyx, Inc. Sued for Securities Law ViolationsContact Levi & Korsinsky Before October 15, 2024 to Discuss Your RightsARDX | NDAQ:ARDX | Press Release - Stockhouse Publishing
Levi & Korsinsky Reminds Ardelyx, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 15, 2024ARDX - AccessWire
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Ardelyx, Inc. of Class Action Lawsuit and Upcoming DeadlinesARDX - PR Newswire
Shareholders of Ardelyx, Inc. Should Contact Levi & Korsinsky Before October 15, 2024 to Discuss Your RightsARDX - AccessWire
Profund Advisors LLC Cuts Holdings in Ardelyx, Inc. (NASDAQ:ARDX) - Defense World
ARDX Investors Have Opportunity to Lead Ardelyx, Inc.Securities Fraud Lawsuit with the Schall Law Firm - Kilgore News Herald
Technical analysis of Ardelyx Inc (ARDX) stock chart patterns - US Post News
Ardelyx: Despite Decent Uptake, We Need More Clarity On The Lawsuit (NASDAQ:ARDX) - Seeking Alpha
Shareholders of Ardelyx, Inc. Should Contact The Gross Law - GlobeNewswire
ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Ardelyx, Inc. - GlobeNewswire
Ardelyx, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before October 15, 2024 to Discuss Your Rights – ARDX - AccessWire
ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Ardelyx, Inc. Investors to Secure Counsel Before Important - EIN News
ARDX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
ARDX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Ardelyx, Inc. Investors Can Join the Class Action Lawsuit! - GlobeNewswire Inc.
ARDX CLASS ACTION REMINDERRobbins LLP Reminds Ardelyx, Inc. Investors of the Pending Lead Plaintiff - Daily Guardian Canada
Ardelyx, Inc. Sued for Securities Law ViolationsInvestors Should Contact Levi & Korsinsky for More InformationARDX - AccessWire
ARDX CLASS ACTION REMINDERRobbins LLP Reminds Ardelyx, - GlobeNewswire
Ardelyx Inc [ARDX] Insider Rosenbaum David P. sells 5,312 Shares – Company Insider Activity - Knox Daily
Trading Day Triumph: Ardelyx Inc (ARDX) Ends at 5.92, a -3.43 Surge/Plunge - The Dwinnex
Ardelyx Inc Stock (ARDX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.05%
4.86%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):